AI-generated from publicly available materials.Oracle has been recognized as a Leader in the IDC MarketScape for its contributions to real-world data (RWD) and real-world evidence (RWE) solutions within the life sciences sector.
This acknowledgment highlights Oracle's extensive history in delivering RWD/RWE solutions that enhance regulatory submission processes, market access, and product commercialization strategies. Over the past four decades, the company has aggregated electronic health record (EHR) data and recently expanded its offerings through the acquisition of Cerner and the launch of an AI-driven life sciences platform.
According to IDC's report, Oracle's integrated approach combines real-world data with technological and regulatory expertise, positioning the company as a valuable partner for life sciences organizations at various research stages. The platform boasts capabilities such as natural language processing, cohort identification, and safety signal detection, which can significantly aid in clinical research and regulatory submissions.
As noted by Oracle executives, this recognition underscores their commitment to leveraging AI and real-world data to empower decision-making in life sciences. The company's initiatives aim to transform data into actionable insights, ultimately enhancing the development of innovative treatments. This leadership position in the market reflects the growing importance of RWD/RWE in the pharmaceutical industry, as organizations increasingly seek data-driven solutions to navigate complex regulatory environments and improve patient outcomes.